BAIA
GSK icon

Bel Air Investment Advisors’s GSK GSK Stock Holding History

Bel Air Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$1.59M Buy
25,404
+2,904
+13% +$187K 0.22% 47
2013
Q2 		$1.41M Buy
+22,500
New +$1.43M 0.21% 46

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bel Air Investment Advisors's GSK Position: Q3 2013 in Review

Bel Air Investment Advisors increased its GSK (GSK) stake by 13% in Q3 2013, buying an estimated $187K and bringing the position to 25,404 shares worth $1.59M. The position accounts for 0.22% of the portfolio, ranked #47.

Bel Air Investment Advisors first reported a position in GSK in Q2 2013 and has held it in 2 quarters since. 635 funds tracked by Wall St. Rank hold GSK as of Q3 2013.

  • Bel Air Investment Advisors held 25,404 shares of GSK worth $1.59M as of Q3 2013.
  • Bel Air Investment Advisors bought 2,904 GSK shares in Q3 2013, an estimated $187K.
  • GSK made up 0.22% of Bel Air Investment Advisors's portfolio in Q3 2013, its #47 holding.
  • Bel Air Investment Advisors first reported a position in GSK in Q2 2013 and has held it in 2 quarters since.
  • 635 funds tracked by Wall St. Rank held GSK as of Q3 2013.

Based on Bel Air Investment Advisors's 13F filing for Q3 2013, filed 12 Nov 2013.